专题:Cutaneous lymphoproliferative disorders research

This cluster of papers focuses on the classification, staging, treatment, and prognosis of cutaneous lymphomas, with a specific emphasis on mycosis fungoides and Sézary syndrome. It includes discussions on the WHO-EORTC classification, survival outcomes, prognostic factors, and various treatment options such as bexarotene and denileukin diftitox. The cluster also addresses the incidence patterns, genomic landscape, and molecular profiling of cutaneous T-cell lymphomas.
最新文献
A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry

article Full Text OpenAlex

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

article Full Text OpenAlex

Targeting TAG-72 in cutaneous T cell lymphoma

article Full Text OpenAlex

Efficacy of Fractional Versus Fully Ablative CO2 Laser for Distolateral Onychomycosis: Experience With 20 Patients

article Full Text OpenAlex

Primary cutaneous lymphoproliferations in the gray zone between marginal zone lymphoma and CD4+ small/medium T‐cell lymphoproliferative disease

article Full Text OpenAlex

Efficacy and safety of azathioprine versus mycophenolate mofetil in chronic actinic dermatitis in skin of color: results of a randomized controlled trial

article Full Text OpenAlex

Topical tirbanibulin ointment 1% as a potential new treatment for recalcitrant plantar warts: a case report

letter Full Text OpenAlex

Increased Risk of Cutaneous T‐Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis

article Full Text OpenAlex

Clinical response to oclacitinib in canine cutaneous epitheliotropic T-cell lymphoma: A case reports

article Full Text OpenAlex

Molecular Signature of miR‐34a/NEAT‐1/p53 Axis in Mycosis Fungoides

article Full Text OpenAlex

近5年高被引文献
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

article Full Text OpenAlex 676 FWCI364.05454288

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

article Full Text OpenAlex 675 FWCI83.40840274

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

article Full Text OpenAlex 543 FWCI80.73886477

CAR T-cell therapy in autoimmune diseases

review Full Text OpenAlex 273 FWCI64.86398825

The incidence and clinical analysis of non-melanoma skin cancer

article Full Text OpenAlex 247 FWCI36.58903903

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

article Full Text OpenAlex 231 FWCI29.89416204

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches

review Full Text OpenAlex 215 FWCI32.10874854

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

article Full Text OpenAlex 199 FWCI41.88461808

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

article Full Text OpenAlex 199 FWCI99.44723391

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

article Full Text OpenAlex 180 FWCI96.79441317